Financial toxicity: Difference between revisions
CSV import |
No edit summary Tag: Manual revert |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 26: | Line 26: | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | |||
Latest revision as of 18:34, 18 March 2025
Financial Toxicity is a term used to describe the financial burden experienced by patients due to the high cost of medical care, particularly in the context of cancer treatment. This burden can lead to significant stress and anxiety, negatively impacting a patient's overall health and well-being.
Definition[edit]
Financial Toxicity is defined as the financial distress or hardship experienced by patients due to the cost of their medical care. This can include the direct costs of treatment, such as medication and hospital stays, as well as indirect costs, such as lost income due to inability to work.
Causes[edit]
The primary cause of financial toxicity is the high cost of medical care. This can be exacerbated by a number of factors, including lack of insurance, underinsurance, and high out-of-pocket costs. Additionally, certain treatments, such as cancer treatment, can be particularly expensive, leading to a higher risk of financial toxicity.
Impact[edit]
Financial toxicity can have a significant impact on a patient's health and well-being. The stress and anxiety associated with financial hardship can lead to poorer health outcomes, including decreased quality of life and increased risk of mortality. Additionally, financial toxicity can lead to treatment non-adherence, as patients may be unable to afford their medications or other necessary treatments.
Management[edit]
Management of financial toxicity involves a combination of strategies, including financial counseling, assistance programs, and policy changes. Financial counseling can help patients understand their financial situation and explore options for reducing their financial burden. Assistance programs, such as those offered by pharmaceutical companies and non-profit organizations, can help cover the cost of medications and other treatments. Policy changes, such as increased transparency in healthcare pricing and improved insurance coverage, can also help reduce the risk of financial toxicity.
